NDC 70000-0263-01 - LEADER CHILDRENS IBUPROFEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70000-0263
- Requested NDC
- 70000-0263-01
- Package NDCs from labels
- 70000-0263-1, 70000-0263-2, 70000-0263-3, 70000-0263-01
- Manufacturer
- Cardinal Health 110, LLC. dba Leader
- Effective date
- 2025-03-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LEADER CHILDRENS IBUPROFEN - Cardinal Health 110, LLC. dba Leader | Cardinal Health 110, LLC. dba Leader | 2025-03-03 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 120 mL in 1 BOTTLE | SUSPENSION | 120 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 240 mL in 1 BOTTLE | SUSPENSION | 240 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 150 mL in 1 BOTTLE | SUSPENSION | 150 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70000-0263 | LEADER CHILDRENS IBUPROFEN (IBUPROFEN) SUSPENSION [CARDINAL HEALTH 110, LLC. DBA LEADER] | 5 | Current NDC, Legacy NDC, 6 package rows | 20250305_913a4bd0-0784-45b4-b05e-3e7c016bbb86.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70000-0263-1 | ML - Milliliter | 70000-0263 | fbb179f2-5d83-4b39-a4c8-7f816a8d06e2 | 1 | 2017-11-06 |
| 70000-0263-2 | ML - Milliliter | 70000-0263 | fbe88e6f-ef78-4794-b3b0-585c7211eea8 | 1 | 2017-11-06 |
| 70000-0263-3 | ML - Milliliter | 70000-0263 | 5146b58d-9db9-4309-b673-3ed748b15b86 | 1 | 2018-03-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eye Wash | WATER | CMC Group Inc. | 6158a1f5-a6bc-4a3e-9d1d-0a310d9dc561 | 2025-04-02 | Warnings | 059QF0KO0R |
| dg health ibuprofen | IBUPROFEN | Dolgencorp Inc | 74f46147-b4c2-4bb3-bd0a-220c0a5403a6 | 2025-04-01 | Warnings | WK2XYI10QM |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Ailex Pharmaceuticals, LLC | 329655ae-c3c0-46b2-a925-e49777f2076b | 2025-03-30 | Warnings, Adverse reactions | OJ245FE5EU |
| good sense ibuprofen | IBUPROFEN | L. Perrigo Company | 0cb4b0ef-5cdd-4c79-8718-4fb157a2c948 | 2025-03-29 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Aphena Pharma Solutions - Tennessee, LLC | 3140a614-c7ae-3062-e063-6394a90ad3d7 | 2025-03-26 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| good sense ibuprofen | IBUPROFEN | L. Perrigo Company | 3b78c004-e4fe-449c-86e9-52e8ccf12785 | 2025-03-25 | Warnings | WK2XYI10QM |
| Ibuprofen PM | DIPHENHYDRAMINE CITRATE, IBUPROFEN | WR Group, Inc. | 1e2feaf0-7fff-43d5-bcfe-9f2851bdc805 | 2025-03-25 | Warnings | WK2XYI10QM |
| Ibuprofen minis | IBUPROFEN | WR Group, Inc. | e9dad35a-6789-42d6-97da-521db7b16496 | 2025-03-24 | Warnings | WK2XYI10QM |
| basic care ibuprofen | IBUPROFEN | Amazon.com Services LLC | 25bc5cc2-9b6a-47e4-8b3d-2bb370907b61 | 2025-03-20 | Warnings | WK2XYI10QM |
| basic care ibuprofen | IBUPROFEN | Amazon.com Services LLC | cd15159a-9ed5-453a-9ad4-0c9688204c82 | 2025-03-19 | Warnings | WK2XYI10QM |
| equate ibuprofen pm | DIPHENHYDRAMINE CITRATE, IBUPROFEN | Wal-Mart Stores Inc | e36957ed-653c-465f-8150-7d6073e1376f | 2025-03-16 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | ce5b0429-bbe1-47a4-af5e-0159d3cfd2c3 | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Care One (Retail Business Services, LLC.) | a6ce7484-7a32-4985-80bc-883c31be3525 | 2025-03-12 | Warnings | WK2XYI10QM |
| Addiclenz | ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, BETA VULGARIS, BISPHENOL A, BOLDO, CHELIDONIUM MAJUS, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PETROSELINUM SATIVUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, TARAXACUM OFFICINALE, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 25036c26-1c21-4e5a-b4db-b8e177458341 | 2025-03-11 | Warnings | OJ245FE5EU |
| Sudafed PE Head Congestion Plus Pain | IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | 76513fb2-7323-4f1f-8a10-92f8f603cf97 | 2025-03-10 | Warnings | WK2XYI10QM |
| Curist Hemorrhoid Fissure Relief | LIDOCAINE | Little Pharma, Inc | 2fb02b00-acdb-5184-e063-6294a90ae1c8 | 2025-03-06 | Warnings | PDC6A3C0OX |
| Redicare Ibuprofen 200mg | IBUPROFEN 200MG | Redicare LLC | 2f0db953-33e2-1729-e063-6294a90af074 | 2025-03-04 | Warnings, Adverse reactions | WK2XYI10QM |
| Thera Plus Hemorrhoidal | GLYCERIN, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE | FOURSTAR GROUP USA, INC. | 87143a7a-7b2d-4b67-afda-2355697e7300 | 2025-03-04 | Warnings | PDC6A3C0OX |
| LEADER CHILDRENS IBUPROFEN | IBUPROFEN | Cardinal Health 110, LLC. dba Leader | 913a4bd0-0784-45b4-b05e-3e7c016bbb86 | 2025-03-03 | Warnings | ANDA074937 70000-0263-1 70000-0263-3 70000-0263-2 70000-0263 70000026301 197803 190f0279-7683-440a-aec8-7ee9445c1f9b 913a4bd0-0784-45b4-b05e-3e7c016bbb86 WK2XYI10QM |
| equate ibuprofen | IBUPROFEN | Wal-Mart Stores Inc | 2daee8c1-d05e-406b-af65-b81bbbaa244d | 2025-03-03 | Warnings | ANDA074937 197803 WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.